Through a merger between INC Research and inVentiv Health in 2018, Syneos Health has become the industry’s only fully integrated biopharmaceutical solutions organisation which includes one of the world’s top three global clinical research organisations (CRO) and a contract commercial organisation (CCO). Rosa Gonzalez Galindo explains the scale and scope of Syneos Health’s services, along with the key success factors for the company both now and for the future.
Because our clinical and commercial experts live under the same roof, they are able to constantly share real-world knowledge and insights that lead to getting the job done better, smarter and faster increasing the likelihood of regulatory approval and maximizing commercial success
